255 related articles for article (PubMed ID: 27465291)
21. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
[TBL] [Abstract][Full Text] [Related]
22. Stromal changes in the aged lung induce an emergence from melanoma dormancy.
Fane ME; Chhabra Y; Alicea GM; Maranto DA; Douglass SM; Webster MR; Rebecca VW; Marino GE; Almeida F; Ecker BL; Zabransky DJ; Hüser L; Beer T; Tang HY; Kossenkov A; Herlyn M; Speicher DW; Xu W; Xu X; Jaffee EM; Aguirre-Ghiso JA; Weeraratna AT
Nature; 2022 Jun; 606(7913):396-405. PubMed ID: 35650435
[TBL] [Abstract][Full Text] [Related]
23. Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.
Muzes G; Sipos F
Anticancer Agents Med Chem; 2017; 17(4):472-482. PubMed ID: 27592547
[TBL] [Abstract][Full Text] [Related]
24. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
25. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
[TBL] [Abstract][Full Text] [Related]
26. The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.
Fenouille N; Robert G; Tichet M; Puissant A; Dufies M; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Pigment Cell Melanoma Res; 2011 Feb; 24(1):219-32. PubMed ID: 20955243
[TBL] [Abstract][Full Text] [Related]
27. Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites.
Li X; Karras P; Torres R; Rambow F; van den Oord J; Marine JC; Kos L
Cell Rep; 2020 Jun; 31(11):107765. PubMed ID: 32553158
[TBL] [Abstract][Full Text] [Related]
28. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
Zanella F; Renner O; García B; Callejas S; Dopazo A; Peregrina S; Carnero A; Link W
Oncogene; 2010 May; 29(20):2973-82. PubMed ID: 20208562
[TBL] [Abstract][Full Text] [Related]
29. Dormancy activation mechanism of oral cavity cancer stem cells.
Chen X; Li X; Zhao B; Shang D; Zhong M; Deng C; Jia X
Tumour Biol; 2015 Jul; 36(7):5551-9. PubMed ID: 25722113
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
[TBL] [Abstract][Full Text] [Related]
31. A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection.
Klimkiewicz K; Weglarczyk K; Collet G; Paprocka M; Guichard A; Sarna M; Jozkowicz A; Dulak J; Sarna T; Grillon C; Kieda C
Cancer Lett; 2017 Jun; 396():10-20. PubMed ID: 28288873
[TBL] [Abstract][Full Text] [Related]
32. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
[TBL] [Abstract][Full Text] [Related]
33. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment.
Bleau AM; Agliano A; Larzabal L; de Aberasturi AL; Calvo A
Histol Histopathol; 2014 Dec; 29(12):1499-510. PubMed ID: 24887025
[TBL] [Abstract][Full Text] [Related]
34. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
35. Dormancy and quiescence of skeletal muscle stem cells.
Rocheteau P; Vinet M; Chretien F
Results Probl Cell Differ; 2015; 56():215-35. PubMed ID: 25344673
[TBL] [Abstract][Full Text] [Related]
36. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C downregulation induces senescence via FoxO3a inhibition in HCT116 and HEK293 cells.
Park JW; Lee YH; Bae YS
Biochem Biophys Res Commun; 2017 Dec; 493(4):1548-1554. PubMed ID: 28989024
[TBL] [Abstract][Full Text] [Related]
38. Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.
Senft D; Ronai ZA
Pigment Cell Melanoma Res; 2016 Jan; 29(1):27-42. PubMed ID: 26514653
[TBL] [Abstract][Full Text] [Related]
39. Involvement of FKHRL1 in melanoma cell survival and death.
Hilmi C; Larribere L; Deckert M; Rocchi S; Giuliano S; Bille K; Ortonne JP; Ballotti R; Bertolotto C
Pigment Cell Melanoma Res; 2008 Apr; 21(2):139-46. PubMed ID: 18426407
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
